Advertisement

Neuroscience and Behavioral Physiology

, Volume 49, Issue 3, pp 357–364 | Cite as

Synergistic Application of Zinc and Vitamin C to Support Memory and Attention and to Decrease the Risk of Developing Nervous System Diseases

  • O. A. GromovaEmail author
  • I. Yu. Torshin
  • A. V. Pronin
  • M. A. Kilchevsky
Article
  • 8 Downloads

Provision of the body with zinc and vitamin C is important for CNS functioning. Zinc ions take part in neurotransmission (transmission of signals from acetylcholine, catecholamine, serotonin, and prostaglandin receptors) and in ubiquitin-dependent protein degradation. Zinc deficiency is associated with the development of Alzheimer’s disease and depression. Zinc supplementation (10–30 mg/day) improves neurological recovery in patients with stroke and closed craniocerebral injury and also improves measures of attention; it decreases hyperactivity in children. Vitamin C is a synergist of zinc which supports the antioxidant resources of the brain, synaptic activity, and detoxification. Vitamin C supplements at a dose of 130–500 mg/day are recommended for the prophylaxis of dementia and neurodegenerative pathology.

Keywords

zinc vitamin C dementia neurodegenerative hyperactivity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G. G. Mackenzie, G. A. Salvador, C. Romero, et al., “A deficit in zinc availability can cause alterations in tubulin thiol redox status in cultured neurons and in the developing fetal rat brain,” Free Radic. Biol. Med., 51, No. 2, 480–489 (2011),  https://doi.org/10.1016/j.freeradbiomed.2011.04.028.CrossRefGoogle Scholar
  2. 2.
    I. Yu. Torshin and O. A. Gromova, Expert Data Analysis in Pharmacology, MCNMCO, Moscow (2012).Google Scholar
  3. 3.
    V. G. Rebrov and O. A. Gromova, Vitamins, Macroelements and Trace Elements, GeotarMed, Moscow (2008).Google Scholar
  4. 4.
    A. I. Acuña, M. Esparza, C. Kramm, et al., “A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice,” Nat. Commun., 4, 2917–2919 (2013),  https://doi.org/10.1038/ncomms3917.CrossRefGoogle Scholar
  5. 5.
    I. Yu. Torshin, “Sensing the change from molecular genetics to personalized medicine,” in: Bioinformatics in the Post-Genomic Era, Nova Biomedical Books, New York (2009), ISBN 1-60692-217-0.Google Scholar
  6. 6.
    Y. Kulathu, M. Akutsu, A. Bremm, et al., “Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain,” Nat. Struct. Mol. Biol., 16, No. 12, 1328–1330 (2009),  https://doi.org/10.1038/nsmb.1731.CrossRefGoogle Scholar
  7. 7.
    G. Takaesu, S. Kishida, A. Hiyama, et al., “TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway,” Mol. Cell, 5, No. 4, 49–658 (2000),  https://doi.org/10.1016/s1097-2765(00)80244-0.CrossRefGoogle Scholar
  8. 8.
    S. Lopes da Silva, B. Vellas, S. Elemans, et al., “Plasma nutrient status of patients with Alzheimer’s disease: Systematic review and meta-analysis,” Alzheimers Dement., 10, No. 4, 485–502 (2014),  https://doi.org/10.1016/j.jalz.2013.05.1771.CrossRefGoogle Scholar
  9. 9.
    W. Swardfager, N. Herrmann, G. Mazereeuw, et al., “Zinc in depression: a meta-analysis,” Biol. Psychiatry, 74, No. 12, 872–878 (2013),  https://doi.org/10.1016/j.biopsych.2013.05.008.CrossRefGoogle Scholar
  10. 10.
    R. Aquilani, P. Baiardi, M. Scocchi, et al., “Normalization of zinc intake enhances neurological retrieval of patients suffering from ischemic strokes,” Nutr. Neurosci., 12, No. 5, 219–225 (2009),  https://doi.org/10.1179/147683009X423445.CrossRefGoogle Scholar
  11. 11.
    B. Young, L. Ott, E. Kasarskis, et al., “Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury,” J. Neurotrauma, 13, No. 1, 25–34 (1996),  https://doi.org/10.1089/neu.1996.13.25.CrossRefGoogle Scholar
  12. 12.
    N. B. Mathur and D. K. Agarwal, “Zinc supplementation in preterm neonates and neurological development. A randomized controlled trial,” Indian Pediatr., 52, No. 11, 951–955 (2015),  https://doi.org/10.1007/s13312-015-0751-6.CrossRefGoogle Scholar
  13. 13.
    J. Colombo, N. Zavaleta, K. N. Kannass, et al., “Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6-18 months,” J. Nutr., 144, No. 8, 298–1305 (2014),  https://doi.org/10.3945/jn.113.189365.CrossRefGoogle Scholar
  14. 14.
    J. Zamora, A. Velásquez, L. Troncoso, et al., “Zinc in the therapy of the attention-deficit/hyperactivity disorder in children. A preliminary randomized controlled trial,” Arch. Latinoam. Nutr., 61, No. 3, 242–246 (2011),  https://doi.org/10.1186/isrctn03732556.Google Scholar
  15. 15.
    U. Himmelreich, K. N. Drew, A. S. Serianni, and P. W. Kuchel, “13C NMR studies of vitamin C transport and its redox cycling in human erythrocytes,” Biochemistry, 37, 7578–7588 (1998),  https://doi.org/10.1021/bi970765s.CrossRefGoogle Scholar
  16. 16.
    T. Ishikawa, A. F. Casini, and M. Nishikimi, “Molecular cloning and functional expression of rat liver glutathione-dependent dehydroascorbate reductase,” J. Biol. Chem., 273, 28708–28712 (1998),  https://doi.org/10.1074/jbc.273.44.28708.CrossRefGoogle Scholar
  17. 17.
    M. A. Castro, F. A. Beltrán, S. Brauchi, and I. I. Concha, “A metabolic switch in brain: Glucose and lactate metabolism modulation by ascorbic acid,” J. Neurochem., 110, 423–440 (2009),  https://doi.org/10.1111/j.1471-4159.2009.06151.x.CrossRefGoogle Scholar
  18. 18.
    B. Peterkofsky, “Ascorbate requirement for hydroxylation and secretion of procollagen: Relationship to inhibition of collagen synthesis in scurvy,” Am. J. Clin Nutr., 54, 1135–1140 (1991),  https://doi.org/10.1016/s0174-173x(87)80045-6.CrossRefGoogle Scholar
  19. 19.
    H. Padh, “Cellular functions of ascorbic acid,” Biochem. Cell Biol., 68, 1166–1173 (1990),  https://doi.org/10.1139/o90-173.CrossRefGoogle Scholar
  20. 20.
    M. Levine, Y. Wang, and S. C. Rumsey, “Analysis of ascorbic acid and dehydroascorbic acid in biological samples,” Methods Enzymol., 299, 65–76 (1999),  https://doi.org/10.1002/0471140856.tx0706s12.CrossRefGoogle Scholar
  21. 21.
    G. N. Levine, B. Frei, S. N. Koulouris, et al., “Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease,” Circulation, 93, 1107–1113 (1996),  https://doi.org/10.1161/01.cir.93.6.1107.CrossRefGoogle Scholar
  22. 22.
    M. I. Naseer, N. Ullah, I. Ullah, et al., “Vitamin C protects against ethanol and PTZ-induced apoptotic neurodegeneration in prenatal rat hippocampal neurons,” Synapse, 65, 562–571 (2011),  https://doi.org/10.1002/syn.20875.CrossRefGoogle Scholar
  23. 23.
    I. M. Santos, R. Tome Ada, G. B. Saldanha, et al., “Oxidative stress in the hippocampus during experimental seizures can be ameliorated with the antioxidant ascorbic acid,” Oxid. Med. Cell. Longev., 2, 214–221 (2009),  https://doi.org/10.4161/oxim.2.4.8876.CrossRefGoogle Scholar
  24. 24.
    S. Qiu, L. Li, E. J. Weeber, and J. M. May, “Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity,” J. Neurosci. Res., 85, 1046–1056 (2007),  https://doi.org/10.1002/jnr.21204.CrossRefGoogle Scholar
  25. 25.
    B. Ghasemzadeh, J. Cammack, and R. N. Adams, “Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry,” Brain Res., 547, 162–166 (1991),  https://doi.org/10.1016/0006-8993(91)90587-l.Google Scholar
  26. 26.
    L. Lee, S. A. Kang, H. O. Lee, et al., “Relationships between dietary intake and cognitive function level in Korean elderly people,” Public Health, 115, 133–138 (2001),  https://doi.org/10.1016/s0033-3506(01)00432-2.CrossRefGoogle Scholar
  27. 27.
    R. M. Ortega, A. M. Requejo, P. Andres, et al., “Dietary intake and cognitive function in a group of elderly people,” Am. J. Clin Nutr., 66, 803–809 (1997),  https://doi.org/10.1016/s0033-3506(01)00432-2.CrossRefGoogle Scholar
  28. 28.
    M. C. Polidori, D. Pratico, F. Mangialasche, et al., “High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects,” J. Alzheimers Dis., 17, 921–927 (2009),  https://doi.org/10.3233/jad-2009-1114.CrossRefGoogle Scholar
  29. 29.
    G. McNeill, X. Jia, L. J. Whalley, et al., “Antioxidant and B vitamin intake in relation to cognitive function in later life in the Lothian birth cohort 1936,” Eur. J. Clin. Nutr., 65, No. 5, 619–626 (2011),  https://doi.org/10.1038/ejcn.2011.2.CrossRefGoogle Scholar
  30. 30.
    J. S. Goodwin, J. M. Goodwin, and P. J. Garry, “Association between nutritional status and cognitive functioning in a healthy elderly population,” JAMA, 249, No. 21, 2917–2921 (1983),  https://doi.org/10.1001/JAMA.1983.03330450047024.CrossRefGoogle Scholar
  31. 31.
    C. R. Gale, C. N. Martyn, and C. Cooper, “Cognitive impairment and mortality in a cohort of elderly people,” BMJ, 312, 608–611(1996),  https://doi.org/10.1136/BMJ.312.7031.608.CrossRefGoogle Scholar
  32. 32.
    W. J. Perrig, P. Perrig, and H. B. Stahelin, “The relation between antioxidants and memory performance in the old and very old,” J. Am. Geriatr. Soc., 45, 718–724 (1997),  https://doi.org/10.1111/j.1532-5415.1997.tb01476.x.CrossRefGoogle Scholar
  33. 33.
    H. J. Wengreen, R. G. Munger, C. D. Corcoran, et al., “Antioxidant intake and cognitive function of elderly men and women: the Cache County Study,” J. Nutr. Health Aging, 11, 230–237 (2007),  https://doi.org/10.1016/s0197-4580(04)81561-6.Google Scholar
  34. 34.
    R. D. O’Neill, M. Fillenz, L. Sundstrom, and J. N. Rawlins, “Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat,” Neurosci. Lett., 52, 227–233 (1984),  https://doi.org/10.1016/0304-3940(84)90166-6.CrossRefGoogle Scholar
  35. 35.
    P. Rinaldi, M. C. Polidori, A. Metastasio, et al., “Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease,” Neurobiol. Aging, 24, 915–919 (2003),  https://doi.org/10.1016/s0197-4580(03)00031-9.CrossRefGoogle Scholar
  36. 36.
    K. C. Fitzgerald, E. J. O’Reilly, E. Fondell, et al., “Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: Pooled results from 5 cohort studies,” Ann. Neurol., 73, 236–245 (2013),  https://doi.org/10.1002/ana.23820.CrossRefGoogle Scholar
  37. 37.
    K. H. Masaki, K. G. Losonczy, G. Izmirlian, et al., “Association of vitamin E and C supplement use with cognitive function and dementia in elderly men,” Neurology, 54, 1265–1272 (2000),  https://doi.org/10.1212/wnl.54.6.1265.CrossRefGoogle Scholar
  38. 38.
    M. J. Engelhart, M. I. Geerlings, A. Ruitenberg, et al., “Dietary intake of antioxidants and risk of Alzheimer disease,” JAMA, 287, No. 24, 3223–3229 (2002),  https://doi.org/10.1001/jama.287.24.3223.CrossRefGoogle Scholar
  39. 39.
    A. Neymotin, S. Petri, N. Y. Calingasan, et al., “Lenalidomide (revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis,” Exp. Neurol., 220, 191–197 (2009),  https://doi.org/10.1016/j.expneurol.2009.08.028.CrossRefGoogle Scholar
  40. 40.
    K. Okamoto, T. Kihira, G. Kobashi, et al., “Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan,” Neuroepidemiology, 32, No. 4, 251–256 (2009), Epub 2009 Feb 11, 10.1159/000201563.Google Scholar
  41. 41.
    G. V. Rebec and R. C. Pierce, “A vitamin as neuromodulator: Ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission,” Prog. Neurobiol., 43, 537–565 (1994),  https://doi.org/10.1016/0301-0082(94)90052-3.CrossRefGoogle Scholar
  42. 42.
    J. L. Dorner, B. R. Miller, E. L. Klein, et al., “Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington’s disease,” Brain Res., 1290, 111–120 (2009),  https://doi.org/10.1016/j.brainres.2009.07.019.CrossRefGoogle Scholar
  43. 43.
    K. Ide, H. Yamada, K. Umegaki, et al., “Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson’s disease,” Nutrition, 31, No. 2, 406–408 (2015),  https://doi.org/10.1016/j.nut.2014.08.001.CrossRefGoogle Scholar
  44. 44.
    H. Nagayama, M. Hamamoto, M. Ueda, et al., “The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease,” Clin. Neuropharmacol., 27, 270–273 (2004),  https://doi.org/10.1097/01.wnf.0000150865.21759.bc.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • O. A. Gromova
    • 1
    Email author
  • I. Yu. Torshin
    • 2
  • A. V. Pronin
    • 1
  • M. A. Kilchevsky
    • 1
  1. 1.Ivanovo State Medical Academy, Ministry of Health of the Russian FederationIvanovoRussia
  2. 2.Moscow Institute of Physics and Technology (State University)DolgoprudnyiRussia

Personalised recommendations